|
Index of reports
> Cases resulting in death (5)
> Cases with Cardiovascular Disorder (2)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in death where reactions include cardiovascular disorder.
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-02-05
Patient: male
Adverse reactions / side effects: Cardiovascular Disorder
Adverse event resulted in: death
Suspect drug(s):
Botox
Dosage: unk, unk
Indication: Torticollis
Start date: 2004-12-01
End date: 2004-12-01
Botox
Start date: 2005-02-02
End date: 2005-02-02
Botox
Start date: 2005-04-06
End date: 2005-04-06
Botox
Start date: 2005-06-08
End date: 2005-06-08
Botox
Start date: 2005-08-24
End date: 2005-08-24
Botox
Start date: 2005-10-26
End date: 2005-10-26
Other drugs received by patient: Alimemazine Tartrate; Sucralfate; Riboflavin TAB; Diastase; Dimeticone; Amlodipine Besylate; Benzbromarone; Propiverine Hydrochloride; Losartan Potassium; Nizatidine; Sennoside / 00571902 /
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-01-29
Patient: male
Adverse reactions / side effects: Cardiovascular Disorder
Adverse event resulted in: death
Suspect drug(s):
Botox (Botulinum Toxin Type A)
|
